Inhibition of human initiator caspase 8 and effector caspase 3 by cross-class inhibitory bovSERPINA3-1 and A3-3

FEBS Letters

Volumn 583, Issue 17, 2009, Pages 2743-2748

  Herrera Mendez, Carlos H ^d   Becila, Samira ^c   Blanchet, Xavier ^b   Pelissier, Patrick ^b   Delourme, Didier ^b   Coulis, Gerald ^a   Sentandreu, Miguel A ^e   Boudjellal, Abdelghani ^c   Bremaud, Laure ^b   Ouali, Ahmed ^a  

^a UR370 QuaPA   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c Universite Mentouri Constantine   (Algeria)

^d UNIVERSITY OF GUANAJUATO   (Mexico)

^e CSIC   (Spain)

Author keywords

Bovine muscle; bovSERPINA3; Caspase; Inhibitor; Serpin

Indexed keywords

CASPASE 3; CASPASE 8; SERINE PROTEINASE INHIBITOR; SERPIN A3-1; SERPIN A3-3; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; COW; ENZYME ACTIVE SITE; ENZYME INHIBITION; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CASPASE 3; CASPASE 8; CATALYTIC DOMAIN; CATTLE; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT; SERPINS; SUBSTRATE SPECIFICITY;

BOVINAE;

EID: 69349105526     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.07.055     Document Type: Article

References (25)

1. Potempa J., Korzus E., and Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269 (1994) 15957-15960
2. Patterson S.D. Mammalian a1-antichymotrypsins: comparative biochemistry and genetics of the major plasma serpin. Comp. Biochem. Physiol. B. - Comp. Biochem. 100 (1991) 439-454
3. Davies M.J., and Lomas D.A. The molecular aetiology of the serpinopathies. Int. J. Biochem. Cell Biol. 40 (2008) 1273-1286
4. Gettins P.G.W. Serpin structure, mechanism, and function. Chem. Rev. 102 (2002) 4751-4803
5. Hook V.Y.H., Purviance R.T., Azaryan A.V., Hubbard G., and Krieger T.J. Purification and characterization of alpha 1-antichymotrypsin-like protease inhibitor that regulates prohormone thiol protease involved in enkephalin precursor processing. J. Biol. Chem. 268 (1993) 20570-20577
6. Hwang S.-R., Steineckert B., Yasothornsrikul S., Sei C.A., Toneff T., Rattan J., and Hook V.Y.H. Molecular cloning of endopin 1, a novel serpin localized to neurosecretory vesicles of chromaffin cells. J. Biol. Chem. 274 (1999) 34164-34173
7. Hwang S.-R., Garza C.Z., Wegrzyn J.L., and Hook V.Y.H. Demonstration of GTG as an alternative initiation codon for the serpin endopin 2B-2. Biochem. Biophys. Res. Commun. 327 (2005) 837-844
8. Stennicke H.R., Ryan C.A., and Salvesen G.S. Reprieval from execution: the molecular basis of caspase inhibition. Trends Biochem. Sci. 27 (2002) 94-101
9. Dobo J., Swanson R., Salvesen G.S., Olson S.T., and Gettins P.G.W. Cytokine response modifier A inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer. J. Biol. Chem. 281 (2006) 38781-38790
10. Annand R.R., Dahlen J.R., Sprecher C.A., de Deu P., Foster D.C., Mankovich J.A., Talanian R.V., Kisiel W., and Giegel D. Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem. J. 342 (1999) 655-665
11. Bird C.H., Sutton V.R., Sun J., Hirst C.E., Novak A., Kumar S., Trapani J.A., and Bird P.I. Selective regulation of apoptosis: The cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol. Cell Biol. 18 (1998) 6387-6398
12. Pélissier P., Delourme D., Germot A., Blanchet X., Becila S., Maftah A., Leveziel H., Ouali A., and Brémaud L. An original SERPINA3 gene cluster: Elucidation of genomic organization and gene expression in the Bos taurus 21q24 region. BMC genomics 9 (2008) 151-165
13. Tassy C., Herrera-Mendez C.H., Sentandreu M.A., Aubry L., Brémaud L., Pélissier P., Delourme D., Brillard M., Gauthier F., Levéziel H., and Ouali A. Muscle endopin 1, a muscle intracellular serpin which strongly inhibits elastase: purification, characterization, cellular localization and tissue distribution. Biochem. J. 388 (2005) 273-280
14. Herrera-Mendez C.H., Brémaud L., Coulis G., Pélissier P., Sentandreu M.A., Aubry L., Delourme D., Chambon C., Maftah A., Levéziel H., and Ouali A. Purification of the skeletal muscle protein Endopin 1B and characterization of the genes encoding Endopin 1A and 1B isoforms. FEBS Lett. 580 (2006) 3477-3484
15. Stennicke H.R., and Salvesen G.S. Caspases: preparation and characterization. Methods 17 (1999) 313-319
16. Komiyama T.S., Ray C.A., Pickup D.J., Howard A.D., Thornberry N.A., Peterson E.P., and Salvesen G. Inhibition of interleukin-lP converting enzyme by the cowpox virus serpin CrmA: an example of cross-class inhibition. J. Biol. Chem. 269 (1994) 19331-19337
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
18. Fuentes-Prior P., and Salvesen G.S. The protein structures that shape caspase-activity, specificity, activation, and inhibition. Biochem. J. 384 (2004) 201-232
19. Taylor R.C., Cullen S.P., and Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9 (2008) 231-241
20. Schechter N.M., and Plotnick M.I. Measurement of the kinetic parameters mediating protease-serpin inhibition. Methods 32 (2004) 159-168
21. Swanson R., Raghavendra M.P., Zhang W., Froelich C., Gettins P.G., and Olson S.T. Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1. J. Biol. Chem. 282 (2007) 2305-2313
22. Hwang S.-R., Steineckert B., Toneff T., Bundey R., Logvinova A.V., Goldsmith P., and Hook V.Y.H. The novel serpin endopin 2 demonstrates cross-class inhibition of papain and elastase: localization of endopin 2 to regulated secretory vesicles of neuroendocrine chromaffin cells. Biochemistry 41 (2002) 10397-10405
23. Hwang S.-R., Stoka V., Turk V., and Hook V. Resistance of cathepsin L compared to elastase to proteolysis when complexed with the serpin endopin 2C, and recovery of cathepsin L activity. Biochem. Biophys. Res. Commun. 340 (2006) 1238-1243
24. Mania-Pramanik J., Potdar S.S., Vadigoppula A., and Sawant S. Elastase: a predictive marker of inflammation and/or infection. J. Clin. Lab. Anal. 18 (2004) 153-158
25. Hook V., Funkelstein L., Lu D., Bark S., Wegrzyn J., and Hwang S.R. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 393-423